期刊文献+

肌萎缩侧索硬化的基因治疗

暂未订购
导出
摘要 肌萎缩侧索硬化(ALS)是一种进行性神经变性疾病,由于上、下运动神经元变性导致延髓、四肢、躯干等部位肌肉逐渐无力和萎缩,确诊后3~5年患者多因呼吸肌麻痹而死亡,目前尚无有效的治疗方法。利鲁唑(riluzole)为谷氨酸拮抗剂,可使ALS患者的生存期平均延长3个月以上,是目前唯一被美国FDA批准的临床药物。其他的治疗措施还包括维生素、神经营养因子及干细胞移植等,但都没有确切效果。基因治疗为治疗ALS提供新的治疗策略。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2014年第7期1992-1995,共4页 Chinese Journal of Gerontology
基金 国家自然科学基金资助项目(30560042 81160161)
  • 相关文献

参考文献9

  • 1LiyingChi,YanKe,ChunLuo,BaolinLi,DavidGozal,BalaramanKalyanaraman,RugaoLiu.Motor Neuron Degeneration Promotes Neural Progenitor Cell Proliferation, Migration, and Neurogenesis in the Spinal Cords of Amyotrophic Lateral Sclerosis Mice[J]. STEM CELLS . 2009 (1)
  • 2Luc Dupuis,Jean-Philippe Loeffler.Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models[J]. Current Opinion in Pharmacology . 2009 (3)
  • 3BRYDEN J.STANLEY,JOE G.HAUPTMAN,MICHELE C.FRITZ,DIANA S.ROSENSTEIN,JENNIFERKINNS.Esophageal Dysfunction in Dogs with Idiopathic Laryngeal Paralysis: A Controlled Cohort Study[J]. Veterinary Surgery . 2010 (2)
  • 4Angelo C. Lepore,Christine Haenggeli,Mehdi Gasmi,Kathie M. Bishop,Raymond T. Bartus,Nicholas J. Maragakis,Jeffrey D. Rothstein.Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1 G93A model of ALS[J]. Brain Research . 2007
  • 5Andrea C. Pardo,Victor Wong,Leah M. Benson,Margaret Dykes,Kohichi Tanaka,Jeffrey D. Rothstein,Nicholas J. Maragakis.Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1 G93A mice[J]. Experimental Neurology . 2006 (1)
  • 6Brooke R Snyder,Nicholas M Boulis,Thais Federici.Viral vector-mediated gene transfer for CNS disease[J]. Expert Opinion on Biological Therapy . 2010 (3)
  • 7Renshi Xu,Chengsi Wu,Yuhui Tao,Juan Yi,Yunzhu Yang,Xiong Zhang,Rugao Liu.Nestin-positive cells in the spinal cord: a potential source of neural stem cells[J]. International Journal of Developmental Neuroscience . 2008 (7)
  • 8William J Marks,Jill L Ostrem,Leonard Verhagen,Philip A Starr,Paul S Larson,Roy AE Bakay,Robin Taylor,Deborah A Cahn-Weiner,A Jon Stoessl,C Warren Olanow,Raymond T Bartus.Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson’s disease: an open-label, phase I trial[J]. Lancet Neurology . 2008 (5)
  • 9J Simon Lunn,Stacey A Sakowski,Thais Federici,Jonathan D Glass,Nicholas M Boulis,Eva L Feldman.Stem cell technology for the study and treatment of motor neuron diseases[J]. Regen. Med. . 2011 (2)

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部